Factors associated with non-use of antipsychotics among older residents with schizophrenia in long-term institutional care

International Journal of Geriatric Psychiatry

Volumn 23, Issue 12, 2008, Pages 1261-1265

  Alanen, Hanna Mari ^a   Finne Soveri, Harriet ^b   Leinonen, Esa ^c,d  

^a Hatanpää Hospital Department of Psychogeriatrics   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antipsychotics; Elderly people; Minimum Data Set; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ARTICLE; DEMENTIA; DRUG INDEPENDENCY; DRUG USE; FEMALE; FINLAND; FUNCTIONAL DISEASE; HUMAN; INDEPENDENCE; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; UNDERWEIGHT; VISUAL IMPAIRMENT;

AGED; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; GERIATRIC ASSESSMENT; HUMANS; LONG-TERM CARE; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; REFUSAL TO TREAT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 61749104614     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2060     Document Type: Article

References (24)

1. Bartels SJ, Mueser KT, Miles KM. 1997. A comparative study of elderly patients with schizophrenia and bipolar disorder in nursing homes and the community. Schizophr Res 27: 181-190.
2. Bowie CR, Moriarty PJ, Harvey PD, et al. 2001. Aggression in elderly schizophrenia patients: a comparison of nursing home and state hospital residents. J Neuropsychiatry Clin Neurosci 13: 357-366.
3. Björkgren MA, Häkkinen U, Finne-Soveri UH, et al. 1999. Validity and reliability of Resource Utilization Groups (RUG-III) in Finnish long-term care facilities. Scand J Public Health 27: 228-234.
4. Burrows AB, Morris JN, Simon SE, et al. 2000. Development of a minimum data set-based depression rating scale for use in nursing homes. Age Ageing 29: 165-172.
5. Casten R, Lawton MP, Pamelee PA, et al. 1998. Psychometric characteristics of the Minimum Data Set I: confirmatory factor analysis. J Am Geriatr Soc 46: 726-735.
6. Chaudhry IA, Shamsi FA, Weitzman ML. 2006. Progressive severe visual loss after long-term withdrawal from thioridazine treatment. Eur J Ophthalmol 16: 651-653.
7. Dwork AJ, Susser ER, Keilp J, et al. 1998. Senile degeneration and cognitive impairment in chronic schizophrenia. Am J Psychiatry 155: 1536-1543.
8. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-mental state'. A. practical method for grading the cognitive state of patients for the clinician. J Psyciatr Res 12: 189-198.
9. Fornaro P, Calabria G, Corallo G, et al. 2002. Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: a dopamine hypothesis. Doc Ophthalmol 105: 41-49.
10. Friedman JI, Harvey PD, Coleman T, et al. 2001. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry 158: 1441-1448.
11. Hartmaier SL, Sloane PD, Guess HA, et al. 1995. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci 50: M128-133.
12. Harvey PD, Silverman JM, Mohs RC, et al. 1999. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Ppsychiatry 45: 32-40.
13. Hawes C, Morris JN, Phillips CD, et al. 1995. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 35: 172-178.
14. Jellinger Ka, Gabriel E. 1999. No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathol 97: 165-169.
15. Jeste DV, Caligiuri MP, Paulsen JS, et al. 1995. Risk of tardive dyskinesia in older patients. A. prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52: 756-765.
16. Lawton MP, Casten R, Pamelee PA, et al. 1998. Psychometric characteristics of the Minimum Data Set II: validity. J Am Geriatr Soc 46: 736-744.
17. Meeks S, Murrell SA. 1997. Mental illness in late life: socio-economic conditions, psychiatric symptoms, and adjustment of long-term sufferers. Psychol Aging 12: 296-308.
18. Morris JN, Fries BE, Mehr DR, et al. 1994. MDS Cognitive Performance Scale. J Gerontol 49: M174-182.
19. Murphy GM Jr., Lim KO, Wieneke E, et al. 1998. No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol Psychiatry 43: 205-209.
20. Palmer BW, Heaton RK, Gladsjo JA, et al. 2002. Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res 55: 205-215.
21. Purohit DP, Perl DP, Haratoutunian V, et al. 1998. Alzheimer disease and related neurodegerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry 55: 205-211.
22. Snowdon J, Day S, Baker W. 2005. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 20: 1146-1152.
23. Suominen M, Muurinen S, Routasalo P, et al. 2005. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 59: 578-583.
24. Wojszel ZB. 2006. Determinants of nutritional status of older people in long-term care settings on the example of the nursing home in Bialystok. Adv Med Sci 51: 168-173.